The Clinical and Translational Sciences Institute, an academic organization focused on advancing healthcare solutions, is partnering with nonprofit Bridge to Cures, Inc., to fund, mentor and grow university startup companies that are focused on providing innovative solutions to healthcare problems.
This weekend, thirteen university startups will be competing in the Healthcare Innovation Pitch (HIP) Launch Event, which will prepare them for the final Pitch Event in December. Two of these companies have been created by Concordia University Wisconsin faculty, while other businesses have been influenced by Concordia students.
Vivoform, develops more effective formulation strategies to getting prescriptions to their targets. This would allow doctors to apply medicines to the exact area of need, rather than traditional methods such as digesting a pill.
Microlitics works to develop phenotypic diagnostics, which aid in effective, personalized healthcare. Through research, physicians will be able to identify how patients respond to certain drugs, and why some patients react differently to the same medication based on their metabolism.
Many healthcare startups are technically driven, and could benefit from having business students collaborate and create a sound business plan. The hope is that a number of Concordia students will be able to continue working with these startups, and will be able to help shape the direction of healthcare and medicine.
In addition to participating in the the HIP event, Concordia business students are creating their own startups. On Thursday, September 24th, students will take part in a “CU Launch” event that will help them collaborate, plan, and even combine their business plans for future success.